Cargando…
RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis
Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer that is associated with significantly high mortality. In spite of advances in IBC diagnoses, the prognosis is still poor compared to non-IBC. Due to the aggressive nature of the disease, we hypothesize that elevated leve...
Autores principales: | Zare, Alaa, Petrova, Alexandra, Agoumi, Mehdi, Amstrong, Heather, Bigras, Gilbert, Tonkin, Katia, Wine, Eytan, Baksh, Shairaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025367/ https://www.ncbi.nlm.nih.gov/pubmed/29874851 http://dx.doi.org/10.3390/cancers10060184 |
Ejemplares similares
-
Erratum: Zare, A. et al. RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis. Cancers, 2018, 10, 184
por: Zare, Alaa, et al.
Publicado: (2018) -
Tumor necrosis factor α-induced protein 3 (A20) is dysregulated in pediatric Crohn disease
por: Zaidi, Deenaz, et al.
Publicado: (2018) -
Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation
por: Salla, Mohamed, et al.
Publicado: (2023) -
Modulator of Apoptosis 1: A Highly Regulated RASSF1A-Interacting BH3-Like Protein
por: Law, Jennifer, et al.
Publicado: (2012) -
RASSF1 Polymorphisms in Cancer
por: Gordon, Marilyn, et al.
Publicado: (2012)